N/A N=12 Evaluating the Effectiveness of an Attachment-Focused Intervention in Preschool Children With FASD
Fetal Alcohol Spectrum Disorder · Attachment Disorders
Primary: Attachment Classification — 0; 0; 0; 0 participants
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
Phase 4 N=100 Effect of Neuromuscular Reversal With Sugammadex on Postoperative Recovery Profile
Postoperative Respiratory Condition
Primary: Mean Lowest Saturation — 96.8; 93.3 percentage of oxygen saturation
N/A N=73 Antidepressant Treatment Plus Cognitive Behavioral Therapy for Generalized Anxiety Disorder in Older Adults
Generalized Anxiety Disorder
Primary: Hamilton Anxiety Rating Scale — 18; 15; 14; 8 participants — p=<.001
Phase 3 N=485 A Study to Compare Denosumab With Zoledronic Acid in Subjects With Bone Metastases From Solid Tumors
Fractures, Bone
Primary: Percent Change (Chg) From Baseline (BL) to Week (Wk)13 in Urinary Amino-terminal Cross-linking Telopeptide of Type I Collagen Corrected for Urine Creatinine (uNTx/uCr)…
N/A N=224 The Effect of Postoperative Incentive Spirometry on Pulmonary Function and Pulmonary Complications in Bariatric Surgery
Obesity, Morbid · Complications of Bariatric Procedures · Pulmonary Atelectasis
Primary: Hypoxia 6 Hours Postoperative — 13; 11 participants
Phase 2 N=62 A Study of Xeloda (Capecitabine) Plus Radiotherapy in Participants With Locally Advanced Rectal Cancer
Colorectal Cancer
Primary: Percentage of Participants With Pathological Complete Response — 16 percentage of participants
Phase 2 N=459 Efficacy and Safety of Adding Alisporivir (DEB025) to Peginterferon (IFN) Alfa-2a (Peg-IFN Alfa-2a) and Ribavirin in Chronic HCV Genotype 1 Patients Who Relapsed or Did Not Respond to Previous Treatment
Hepatitis C
Primary: Percentage of Participants With Complete Early Viral Response Below the Limit of Quantification (cEVR-LOQ) — 48.2; 61.1; 35.5; 74.3 percentage of participants
Phase 3 N=10,010 PeriOperative ISchemic Evaluation-2 Trial
Cardiovascular Disease
Primary: Composite of All-cause Mortality and Nonfatal MI — 173; 194; 178; 161 participants
Phase 2 N=323 Low Vision Intervention Trial II (LOVIT II)
Central Vision Loss From Macular Diseases
Primary: Comparison of Changes in Visual Reading Ability From Baseline to Four Months Later Measured With 48 Item VA Low Vision Visual Functioning Questionnaire — 1.29; 0.95…
Phase 2 N=33 Phase II NCT (Neoadjuvant Chemotherapy) w/ Weekly Abraxane in Combination With Carboplatin & Bevacizumab in Breast Cancer
Breast Cancer
Primary: Number of Patients With Pathologic Complete Response (pCR) — 6 patients
Phase 2 N=68 Intravenous (IV) AMD3100 for Mobilization and Matched Related Transplant for Advanced Hematological Malignancies
Hematologic Neoplasms
Primary: Number of Donors Treated With IV AMD3100 Who Required a Second Collection to Obtain the Minimum CD34/kg (2 X 106) Necessary for Allogeneic Stem Cell Transplant — 10…
Phase 1 N=8 A Study of Intravenous Tamiflu (Oseltamivir) in Children With Influenza
Influenza
Primary: Area Under the Concentration Versus Time Curve From Time Zero to Last Measurable Plasma Concentration (AUClast) of Oseltamivir and Oseltamivir Carboxylate on Day 1…
Phase 4 N=67 Continuous Oral Contraceptive Treatment in Premenstrual Dysphoric Disorder (PMDD)
Premenstrual Dysphoric Disorder
Primary: Pre-Post Change in Premenstrual Symptom Severity — 1.93; 1.73; 1.64 units on a scale
N/A N=51 NuVent™ Revision Study
Chronic Rhinosinusitis
Primary: Navigation to the Desired Sinus Treatment Location and Dilation of the Ostium — 121 Number of sinuses
Phase 2 N=50 N2001-02: I-MIBG With Intensive Chemotherapy and Autologous Stem Cell Rescue for High-Risk Neuroblastoma
Neuroblastoma
Primary: Response (Complete Response, Very Good Partial Response, and Partial Response) at 60-days Post Stem Cell Infusion — 4; 3 participants